Show simple item record

dc.contributor.authorKhabbal, Y.
dc.contributor.authorZaoui, S.
dc.contributor.authorCherrah,Y.
dc.date.accessioned2014-06-17T10:07:34Z
dc.date.available2014-06-17T10:07:34Z
dc.date.issued2013EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/v19/02/EMHJ_2013_19_2_186_191.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/118434
dc.description186-191EN
dc.description.abstractMilk, in addition to its undeniable nutritional and immunological benefits, is an important element for the development of the infant. Warnings, sometimes exaggerated, may prevent the mother and child from enjoying the benefits of both breastfeeding and appropriate medication. This approach is justified by the total absence of investigations on the excretion of drugs in breast milk during clinical trials. The actual risk was evaluated by several classifications; an estimate of the passage of drugs into milk and estimation of infant exposure to the drug are possible and can provide a reliable indicator to better judge the risk to the infant generally we are faced with two different situations: a new treatment during lactation or maintenance treatment already prescribed during pregnancy. If treatment needs to be prescribed for a long period of breastfeeding, a strategic approach is requiredEN
dc.language.isofrEN
dc.subjectPharmaceutical PreparationsEN
dc.subjectRiskEN
dc.subjectInfantEN
dc.subjectMilk, HumanEN
dc.subject.meshBreast FeedingEN
dc.titleMedicines and breastfeeding: assessing the risk of medicines to infantsEN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 19 (‎2)‎, 186-191, 2013


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record